Peijun Li
Research Subjects
Peijun Li has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Shuaishuai Yuan
Division of Cardiovascular Intensive Care (C-ICU), Cardiac and Vascular Center, The University of Hong Kong-Shenzhen Hospital , Guangdong 518000
4 shared publications- Pailing Xie
Division of Cardiovascular Intensive Care (C-ICU), Cardiac and Vascular Center, The University of Hong Kong-Shenzhen Hospital, Guangdong, People's Republic of China
2 shared publications Lingling Li
China Medical University, Shenyang, Liaoning, China
1 shared publication- Minxin Wei
Department of Cardiovascular Surgery, The University of Hong Kong-Shenzhen Hospital
1 shared publication - Pailing Xie
Division of Cardiovascular Intensive Care (C-ICU), Cardiac and Vascular Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China
1 shared publication Tian Pu
The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
1 shared publication
Latest Publications
- Open Access
- 2 May 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 9 (5) , ytaf217
‘Localized’ constrictive pericarditis
- 2 May 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 9 (5) , ytaf217
Open Access‘Localized’ constrictive pericarditis
- Open Access
- 10 July 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (7) , e0290805
The relationship between NLR, LDL-C/HDL-C, NHR and coronary artery disease
Objective: Chronic inflammation and dyslipidemia are key risk factors for atherosclerotic cardiovascular diseases. We retrospectively explored the association between the neutrophil to lymphocyte ratio (NLR), the ratio of low-density lipoprotein cholesterol (LDL-C) to high-density lipoprotein cholesterol (HDL-C), and the neutrophil to HDL-C ratio (NHR), and the severity of coronary lesions in patients with acute coronary syndrome (ACS). Method: In June 2023, we selected 1210 patients who were diagnosed with ACS based on chest pain from January 2017 to December 2022. Of these, 1100 patients with abnormal coronary angiography were categorized into the experimental group, and 110 patients with normal coronary angiography were classified as the control group. We collected routine blood tests, lipid profiles, and coronary angiography results at admission (before coronary angiography). Patients were then stratified into a control group (Gensini score = 0) and an experimental group (Gensini score = 0) based on the Gensini score. The experimental group was further divided into a low score group (Gensini score < 69) and a high score group (Gensini score ≥ 69). Result: 1. Statistically significant differences were observed between the control and experimental groups in terms of gender, age, body mass index (BMI), hypertension, diabetes, smoking history, and counts of neutrophils (NEU), lymphocytes (LYM), monocytes (MON), eosinophils (EOS), red cell distribution width (RDW), total cholesterol (TC), HDL-C, LDL-C, NLR, LDL-C/HDL-C, and NHR (P2 = 0.708). Conclusion: Compared to NLR, LDL-C/HDL-C, and NHR, the combined NLR and LDL-C/HDL-C ratio is a more accurate marker for assessing the severity of coronary artery disease in ACS patients. Its convenience and effectiveness make it a promising tool for early assessment, timely risk stratification, and appropriate clinical intervention, ultimately improving clinical outcomes for ACS patients.
- 10 July 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (7) , e0290805
Open AccessThe relationship between NLR, LDL-C/HDL-C, NHR and coronary artery disease
Objective: Chronic inflammation and dyslipidemia are key risk factors for atherosclerotic cardiovascular diseases. We retrospectively explored the association between the neutrophil to lymphocyte ratio (NLR), the ratio of low-density lipoprotein cholesterol (LDL-C) to high-density lipoprotein cholesterol (HDL-C), and the neutrophil to HDL-C ratio (NHR), and the severity of coronary lesions in patients with acute coronary syndrome (ACS). Method: In June 2023, we selected 1210 patients who were diagnosed with ACS based on chest pain from January 2017 to December 2022. Of these, 1100 patients with abnormal coronary angiography were categorized into the experimental group, and 110 patients with normal coronary angiography were classified as the control group. We collected routine blood tests, lipid profiles, and coronary angiography results at admission (before coronary angiography). Patients were then stratified into a control group (Gensini score = 0) and an experimental group (Gensini score = 0) based on the Gensini score. The experimental group was further divided into a low score group (Gensini score < 69) and a high score group (Gensini score ≥ 69). Result: 1. Statistically significant differences were observed between the control and experimental groups in terms of gender, age, body mass index (BMI), hypertension, diabetes, smoking history, and counts of neutrophils (NEU), lymphocytes (LYM), monocytes (MON), eosinophils (EOS), red cell distribution width (RDW), total cholesterol (TC), HDL-C, LDL-C, NLR, LDL-C/HDL-C, and NHR (P2 = 0.708). Conclusion: Compared to NLR, LDL-C/HDL-C, and NHR, the combined NLR and LDL-C/HDL-C ratio is a more accurate marker for assessing the severity of coronary artery disease in ACS patients. Its convenience and effectiveness make it a promising tool for early assessment, timely risk stratification, and appropriate clinical intervention, ultimately improving clinical outcomes for ACS patients.
- Open Access
- 1 February 2024
- Published by Taylor & Francis in Open Access Emergency Medicine
- Vol. ume 16, 19-28
A Case of Severe Rhabdomyolysis, Acute Myocardial Damage and Multi-Organ Dysfunction Syndrome in a Patient with Novel Coronavirus Pneumonia
In recent years, healthcare systems worldwide have faced the challenge of the severe COVID-19 pandemic. However, cases of severe rhabdomyolysis, acute myocardial damage, and multiple organ dysfunction syndrome (MODS) caused by COVID-19 are currently rare. This report presents a case of severe rhabdomyolysis, acute myocardial damage, and MODS caused by COVID-19. The patient was treated at The University of Hong Kong-Shenzhen Hospital. The purpose of this report is to aid clinicians in quickly identifying and treating similar cases, ultimately improving patient outcomes.
- 1 February 2024
- Published by Taylor & Francis in Open Access Emergency Medicine
- Vol. ume 16, 19-28
Open AccessA Case of Severe Rhabdomyolysis, Acute Myocardial Damage and Multi-Organ Dysfunction Syndrome in a Patient with Novel Coronavirus Pneumonia
In recent years, healthcare systems worldwide have faced the challenge of the severe COVID-19 pandemic. However, cases of severe rhabdomyolysis, acute myocardial damage, and multiple organ dysfunction syndrome (MODS) caused by COVID-19 are currently rare. This report presents a case of severe rhabdomyolysis, acute myocardial damage, and MODS caused by COVID-19. The patient was treated at The University of Hong Kong-Shenzhen Hospital. The purpose of this report is to aid clinicians in quickly identifying and treating similar cases, ultimately improving patient outcomes.
- Open Access
- 1 November 2023
- Published by Taylor & Francis in Research Reports in Clinical Cardiology
- Vol. ume 14, 91-95
Diagnosis of Infective Endocarditis After First Meningitis by Streptococcus gallolyticus: A Case Report
We present a case study of a patient diagnosed with infective endocarditis (IE) following the initial symptom of meningitis caused by Streptococcus gallate subsp. Pasteur. Identification of IE by clinicians is vital for timely treatment measures and can improve patient prognosis. Therefore, increased awareness and knowledge of IE are crucial for prompt and accurate diagnosis and treatment. Atypical clinical manifestations of IE can result in misdiagnosis, highlighting the need for improved clinical identification. In the instance of extended reoccurring fever coupled with damage to the central nervous system, as described in this article, it is crucial to obtain a comprehensive medical history, perform a thorough physical examination, monitor heart murmur changes dynamically, and expediently conduct blood culture and cardiac color Doppler ultrasound to lessen the possibility of erroneous diagnosis and treatment of IE Currently, there are no reported cases of IE associated with streptococcal meningitis in adults in China.
- 1 November 2023
- Published by Taylor & Francis in Research Reports in Clinical Cardiology
- Vol. ume 14, 91-95
Open AccessDiagnosis of Infective Endocarditis After First Meningitis by Streptococcus gallolyticus: A Case Report
We present a case study of a patient diagnosed with infective endocarditis (IE) following the initial symptom of meningitis caused by Streptococcus gallate subsp. Pasteur. Identification of IE by clinicians is vital for timely treatment measures and can improve patient prognosis. Therefore, increased awareness and knowledge of IE are crucial for prompt and accurate diagnosis and treatment. Atypical clinical manifestations of IE can result in misdiagnosis, highlighting the need for improved clinical identification. In the instance of extended reoccurring fever coupled with damage to the central nervous system, as described in this article, it is crucial to obtain a comprehensive medical history, perform a thorough physical examination, monitor heart murmur changes dynamically, and expediently conduct blood culture and cardiac color Doppler ultrasound to lessen the possibility of erroneous diagnosis and treatment of IE Currently, there are no reported cases of IE associated with streptococcal meningitis in adults in China.